NCT04610385 Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy Status UNKNOWN Phase N/A
NCT04604158 Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients Status COMPLETED Phase NA
NCT04603612 The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor. Status COMPLETED Phase NA
NCT04602117 ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer Status WITHDRAWN Phase PHASE1
NCT04601766 A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets Status COMPLETED Phase PHASE1
NCT04593862 Bladder Cancer and ExeRcise Training During IntraVesical ThErapy Status COMPLETED Phase PHASE2
NCT04588168 Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma Status RECRUITING Phase NA
NCT04583553 Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture Status WITHDRAWN Phase N/A
NCT04580485 INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04579133 Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy Status TERMINATED Phase PHASE2
NCT04570176 Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System Status COMPLETED Phase NA
NCT04567719 Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04566393 Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Status AVAILABLE Phase N/A
NCT04555343 Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention Status COMPLETED Phase PHASE1/PHASE2
NCT04553939 Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer Status COMPLETED Phase PHASE2
NCT04543110 Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC Status UNKNOWN Phase PHASE2
NCT04534309 Behavioral Weight Loss Program for Cancer Survivors in Maryland Status COMPLETED Phase NA